Mark Pandori, PhD

mark-picture.jpg

Mark is an Adjunct Professor of Laboratory Medicine at UCSF and the Director of Alameda County Public Health laboratory, where he oversees infectious disease testing. He has over 15 years of experience in diagnostics evaluation and development.

UCSF Profile


Dave Maahs, MD, PhD

Dave_Maahs.jpg

Dr. Maahs is Professor of Pediatrics and Division Chief of Pediatric Endocrinology and co-director of the Stanford Diabetes Research Center at Stanford University. His research interests are to improve care and prevent complications in people with type 1 diabetes (T1D).

Stanford Profile


PJ Utz, MD, PhD

pj-picture.jpeg

Professor Utz is an expert in the study of human and murine autoantibodies and autoantigens, apoptosis signaling pathways, animal models of autoimmunity, proteomics and multiplexed assay development for biomarker discovery. In 2002, he invented the protein microarray for monitoring antibody responses to disease.

Stanford Profile


Darrell Wilson, MD

DarrellWilson.jpg

Dr. Wilson is a Professor of Pediatrics at Stanford University and PI of the Stanford Center for the NIH-funded Type-1 Diabetes TrialNet group. TrialNet conducts clinical trials directed at preventing or delaying the onset of Type 1 diabetes.

Stanford Profile


Bruce Buckingham, MD

Dr. Buckingham is a Professor of Pediatrics in Endocrinology and Diabetes at Stanford University. His research focus is in type 1 diabetes mellitus, continuous glucose sensor, and the development of an artificial pancreas. Other research interests include using continuous glucose monitoring and algorithms to control blood glucose levels in intensive care units.

Stanford Profile


Monica Embers, PhD

Dr. Embers is a Professor of Bacteriology and Parasitology at Tulane School of Medicine and an Investigator at the Tulane Primate research center. Dr. Embers’ research program regarding Borrelia burgdorferi and Lyme disease is centered on three major foci: (1) evaluating antibiotic efficacy against Lyme disease; (2) identifying treatments that can eradicate B. burgdorferi infection; and (3) immunodiagnosis for B. burgdorferi infection and cure. She also serves on the board of the Bay Area Lyme Foundation.

Tulane Profile